CIK 0001408443 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in A8 · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Net income (USD) | -58.4 M | -42.9 M | ||
| Diluted EPS (USD/shares) | -0.75 | -1.39 | -1.38 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-03 | 8-K | FORM 8-K items 8.01,9.01 | 2026-09-03 |
| 2026-08-12 | 8-K | FORM 8-K items 2.02,9.01 | 2026-08-12 |
| 2026-08-12 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-07 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-06-15 | 8-K | FORM 8-K items 5.02,5.07,9.01 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-06-12 | 4 | 4 | 2026-06-10 |
| 2026-05-22 | EFFECT | EFFECT items ,, | |
| 2026-05-20 | CORRESP | CORRESP | |
| 2026-05-18 | UPLOAD | UPLOAD | |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-13 | S-3 | S-3 | |
| 2026-05-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-13 | 8-K | FORM 8-K items 2.02,9.01 | 2026-05-13 |
| 2026-05-13 | 10-Q | 10-Q | 2026-03-31 |
| 2026-04-30 | ARS | ARS | 2025-12-31 |
| 2026-04-30 | DEFA14A | DEFA14A | |
| 2026-04-30 | DEF 14A | FORM DEF 14A | 2026-06-10 |
| 2026-04-20 | 4 | 4 | 2026-04-16 |
| 2026-04-16 | 144 | 144 |
Forms on file (last 1,000): 4 127, 8-K 73, 3 26, SC 13G/A 26, 10-Q 23, CORRESP 13, SC 13G 13, UPLOAD 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=MIST (0.002 USD), /gw/filings/filings?ticker=MIST&form=8-K, /gw/filings/facts?ticker=MIST&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange